Increased Mortality in Seasonal H3N2 Patients Compared with Those with Pandemic 2009 H1N1 in Taiwan, 2009-2010

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2017 Oct 11

PMID 29016325

Citations 4

Authors

Shi-Yu Huang

Wen-Chi Huang

Yi-Chun Chen

Ching-Yen Tsai

Ing-Kit Lee

Affiliations

Soon will be listed here.

Abstract

We conducted a retrospective study to compare clinical and laboratory findings between 1) severe influenza A and mild influenza A and 2) pandemic 2009 H1N1 (pdm09 A/H1) and seasonal H3N2 (A/H3) from 2009 to 2010. A total of 526 (mean age, 13.6 years; 447 pdm09 A/H1, 79 seasonal A/H3) patients were included, 41 (7.8%) with severe influenza (mean age, 28.1 years; 26 pdm09 A/H1, 15 seasonal A/H3). Influenza-associated complications were pneumonia (75.6%), meningoencephalitis (14.6%), acute kidney injury (14.6%), and acute respiratory distress syndrome (12.2%). Patients with seasonal A/H3 were significantly less likely to experience sore throat ( < 0.001), malaise ( < 0.001), and muscle pain ( < 0.001); they were significantly more likely to have hypertension ( < 0.001), diabetes mellitus ( = 0.001), and chronic obstructive pulmonary disease ( < 0.001), delayed hospital presentation ( = 0.001), delayed oseltamivir treatment ( < 0.001), and higher in-hospital mortality ( = 0.02) than patients with pdm09 A/H1. Further comparison between severe pdm09 A/H1 and severe seasonal A/H3 revealed that severe seasonal A/H3 patients (median age, 71 years) were significantly older than patients with severe pdm09 A/H1 (median age, 7 years) ( < 0.001). Comparison between severe influenza and mild influenza, regardless of influenza A subtypes, by multivariate analysis, found that tachypnea (odds ratio [OR] = 44.3, 95% confidence interval [CI] = 15.7-124.6) and delayed oseltamivir therapy ≧ 48 hours after illness onset (OR = 3.7, 95% CI = 1.3-10.5) were independent risk factors for severe influenza. The findings of this study will improve the understanding of the clinical differences between pdm09 A/H1 and seasonal A/H3, and of influenza-associated complications and predictors for severe outcomes that can help to direct clinicians toward the most effective management of influenza patients to reduce the preventable mortality and morbidity.

Citing Articles

Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus.

Shcheblyakov D, Voronina D, Favorskaya I, Esmagambetov I, Alekseeva I, Korobkova A Acta Naturae. 2024; 16(1):101-110.

PMID: 38698957 PMC: 11062109. DOI: 10.32607/actanaturae.27374.

Correlation between Negative Rapid Influenza Diagnostic Test and Severe Disease in Hospitalized Adults with Laboratory-Confirmed Influenza Virus Infection.

Huang P, Su C, Liu S, Kao K, Hsieh Y, Huang C Am J Trop Med Hyg. 2020; 103(4):1642-1648.

PMID: 32876004 PMC: 7543834. DOI: 10.4269/ajtmh.19-0444.

Post-pandemic influenza A/H1N1pdm09 is associated with more severe outcomes than A/H3N2 and other respiratory viruses in adult hospitalisations.

Minney-Smith C, Selvey L, Levy A, Smith D Epidemiol Infect. 2019; 147:e310.

PMID: 31775940 PMC: 7003621. DOI: 10.1017/S095026881900195X.

Burden of medically attended influenza in Norway 2008-2017.

Hauge S, Bakken I, de Blasio B, Haberg S Influenza Other Respir Viruses. 2019; 13(3):240-247.

PMID: 30637942 PMC: 6468058. DOI: 10.1111/irv.12627.

References

Miller M, Viboud C, Balinska M, Simonsen L . The signature features of influenza pandemics--implications for policy. N Engl J Med. 2009; 360(25):2595-8. DOI: 10.1056/NEJMp0903906. View

Wells D, Hopfensperger D, Arden N, Harmon M, Davis J, Tipple M . Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA. 1991; 265(4):478-81. DOI: 10.1001/jama.265.4.478. View

Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand M, Enouf V . Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2008; 48(1):48-56. DOI: 10.1086/594124. View

. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(17):467-70. View

Gordon A, Saborio S, Videa E, Lopez R, Kuan G, Balmaseda A . Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis. 2010; 50(11):1462-7. DOI: 10.1086/652647. View

McGeer A, Green K, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J . Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2008; 45(12):1568-75. DOI: 10.1086/523584. View

Monto A, Gravenstein S, Elliott M, Colopy M, Schweinle J . Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000; 160(21):3243-7. DOI: 10.1001/archinte.160.21.3243. View

. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(19):536-41. View

Glaser C, Winter K, DuBray K, Harriman K, Uyeki T, Sejvar J . A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. Clin Infect Dis. 2012; 55(4):514-20. DOI: 10.1093/cid/cis454. View

10.

Mauad T, Hajjar L, Callegari G, da Silva L, Schout D, Galas F . Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2009; 181(1):72-9. DOI: 10.1164/rccm.200909-1420OC. View

11.

Lee I, Liu J, Wang L, Yang K, Li C, Eng H . 2009 pandemic influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement. Influenza Other Respir Viruses. 2012; 6(6):e152-61. PMC: 4941712. DOI: 10.1111/j.1750-2659.2012.00410.x. View

12.

Monto A . The risk of seasonal and pandemic influenza: prospects for control. Clin Infect Dis. 2008; 48 Suppl 1:S20-5. DOI: 10.1086/591853. View

13.

Simonsen L, Spreeuwenberg P, Lustig R, Taylor R, Fleming D, Kroneman M . Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013; 10(11):e1001558. PMC: 3841239. DOI: 10.1371/journal.pmed.1001558. View

14.

Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C . Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One. 2012; 7(9):e45051. PMC: 3447811. DOI: 10.1371/journal.pone.0045051. View

15.

Chan K, Peiris J, Lim W, Nicholls J, Chiu S . Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol. 2008; 42(1):65-9. DOI: 10.1016/j.jcv.2007.12.003. View

16.

Stanley T . Acute liver failure following influenza B infection. N Z Med J. 1994; 107(986 Pt 1):382. View

17.

Chang Y, van Hal S, Spencer P, Gosbell I, Collett P . Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust. 2010; 192(2):90-3. DOI: 10.5694/j.1326-5377.2010.tb03426.x. View

18.

Finkelman B, Viboud C, Koelle K, Ferrari M, Bharti N, Grenfell B . Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One. 2007; 2(12):e1296. PMC: 2117904. DOI: 10.1371/journal.pone.0001296. View

19.

Ling L, Chow A, Lye D, Tan A, Krishnan P, Cui L . Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis. 2010; 50(7):963-9. DOI: 10.1086/651083. View

20.

Dawood F, Jain S, Finelli L, Shaw M, Lindstrom S, Garten R . Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360(25):2605-15. DOI: 10.1056/NEJMoa0903810. View